Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04809766
Brief Title: Mesothelin-Specific T-Cells (FH-TCR-Tᴍsʟɴ) for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma

First Submitted : March 19, 2021
First Submitted that Met QC Criteria : March 19, 2021
First Posted : March 22, 2021

Last Update Submitted that Met QC Criteria : November 15, 2021
Last Update Posted : November 17, 2021